Cargando…

Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches

Noninvasive tumor growth monitoring is of particular interest for the evaluation of experimental glioma therapies. This study investigates the potential of positron emission tomography (PET) using O-(2-(18)F-fluoroethyl)-L-tyrosine ([(18)F]-FET) to determine tumor growth in a murine glioblastoma (GB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holzgreve, Adrien, Brendel, Matthias, Gu, Song, Carlsen, Janette, Mille, Erik, Böning, Guido, Mastrella, Giorgia, Unterrainer, Marcus, Gildehaus, Franz J., Rominger, Axel, Bartenstein, Peter, Kälin, Roland E., Glass, Rainer, Albert, Nathalie L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906232/ https://www.ncbi.nlm.nih.gov/pubmed/27378835 http://dx.doi.org/10.3389/fnins.2016.00260

Ejemplares similares

Voxel-wise analysis of dynamic (18)F-FET PET: a novel approach for non-invasive glioma characterisation
por: Vomacka, Lena, et al.
Publicado: (2018)

Can Radiomics Provide Additional Information in [(18)F]FET-Negative Gliomas?
por: von Rohr, Katharina, et al.
Publicado: (2022)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment?
por: Unterrainer, Marcus, et al.
Publicado: (2017)

Combination of pre-treatment dynamic [(18)F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
por: Li, Zhicong, et al.
Publicado: (2022)

(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
por: Wiltgen, Tun, et al.
Publicado: (2022)

Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice
por: Overhoff, Felix, et al.
Publicado: (2016)

Cross-Sectional Comparison of Small Animal [(18)F]-Florbetaben Amyloid-PET between Transgenic AD Mouse Models
por: Brendel, Matthias, et al.
Publicado: (2015)

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic (18)F-FET PET?
por: Unterrainer, Marcus, et al.
Publicado: (2021)

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [(18)F]FET PET radiomics
por: Li, Zhicong, et al.
Publicado: (2021)

Response to (225)Ac-PSMA-I&T after failure of long-term (177)Lu-PSMA RLT in mCRPC
por: Ilhan, Harun, et al.
Publicado: (2020)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

Preliminary experience with dosimetry, response and patient reported outcome after (177)Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer
por: Fendler, Wolfgang P., et al.
Publicado: (2016)

Detection of Splenic Tissue Using (99m)Tc-Labelled Denatured Red Blood Cells Scintigraphy—A Quantitative Single Center Analysis
por: Holzgreve, Adrien, et al.
Publicado: (2022)

Increase of TREM2 during Aging of an Alzheimer’s Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
por: Brendel, Matthias, et al.
Publicado: (2017)

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches
por: Bui, Vinh Ngoc, et al.
Publicado: (2023)

Feasibility of [(68)Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation
por: Brendel, Matthias, et al.
Publicado: (2018)

In response to: Anatomy of (18)F-GE180, a failed radioligand for the TSPO protein
por: Albert, Nathalie L., et al.
Publicado: (2020)

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties?
por: Romagna, Alexander, et al.
Publicado: (2016)

Longitudinal [(18)F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model
por: Holzgreve, Adrien, et al.
Publicado: (2022)

Biodistribution and dosimetry for combined [(177)Lu]Lu-PSMA-I&T/[(225)Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
por: Delker, Astrid, et al.
Publicado: (2023)

Toxicity of a combined therapy using the mTOR-inhibitor everolimus and PRRT with [(177)Lu]Lu-DOTA-TATE in Lewis rats
por: Zellmer, Johannes, et al.
Publicado: (2020)

Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment
por: Brendel, M, et al.
Publicado: (2015)

Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after (177)Lu-PSMA-617 Radioligand Therapy
por: Völter, Friederike, et al.
Publicado: (2021)

Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study
por: Blume, Tanja, et al.
Publicado: (2018)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023)

Salvage PRRT with (177)Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
por: Rudisile, S., et al.
Publicado: (2019)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

PSMA Expression in Glioblastoma as a Basis for Theranostic Approaches: A Retrospective, Correlational Panel Study Including Immunohistochemistry, Clinical Parameters and PET Imaging
por: Holzgreve, Adrien, et al.
Publicado: (2021)

(18)F-FDG PET/CT for Response Assessment in Pediatric Sebaceous Carcinoma of the Parotid Gland
por: Holzgreve, Adrien, et al.
Publicado: (2020)

Molecular Imaging with (18)F-FDG PET/CT and (99m)Tc-MIBI SPECT/CT in Osteitis Fibrosa Cystica Generalisata
por: Holzgreve, Adrien, et al.
Publicado: (2021)

Identification of brain regions predicting epileptogenesis by serial [(18)F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy
por: Russmann, Vera, et al.
Publicado: (2017)

In response to: PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects()()
por: Ewers, Michael, et al.
Publicado: (2013)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

APLN/APLNR Signaling Controls Key Pathological Parameters of Glioblastoma
por: Kälin, Roland E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n5c1cvvj57oval77f3ad683595